SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-015850
Filing Date
2020-04-08
Accepted
2020-04-08 11:36:47
Documents
5
Effectiveness Date
2020-04-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A phat-defa14a_20200521.htm DEFA14A 35315
2 GRAPHIC gqqnilsoizsw000001.jpg GRAPHIC 39845
3 GRAPHIC gqqnilsoizsw000003.jpg GRAPHIC 17683
4 GRAPHIC gqqnilsoizsw000004.jpg GRAPHIC 10777
5 GRAPHIC gqqnilsoizsw000002.jpg GRAPHIC 60263
  Complete submission text file 0001564590-20-015850.txt   213901
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39094 | Film No.: 20781485
SIC: 2834 Pharmaceutical Preparations